Jane Street’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.92M | Buy |
482,089
+377,487
| +361% | +$3.07M | ﹤0.01% | 1530 |
|
|
2025
Q1 | $821K | Sell |
104,602
-97,898
| -48% | -$768K | ﹤0.01% | 3298 |
|
|
2024
Q4 | $3.02M | Sell |
202,500
-14,541
| -7% | -$217K | ﹤0.01% | 1642 |
|
|
2024
Q3 | $3.32M | Buy |
217,041
+81,193
| +60% | +$1.24M | ﹤0.01% | 1774 |
|
|
2024
Q2 | $2.07M | Buy |
135,848
+60,939
| +81% | +$928K | ﹤0.01% | 2686 |
|
|
2024
Q1 | $1.41M | Sell |
74,909
-256,581
| -77% | -$4.84M | ﹤0.01% | 2761 |
|
|
2023
Q4 | $6.33M | Buy |
331,490
+220,191
| +198% | +$4.21M | ﹤0.01% | 1294 |
|
|
2023
Q3 | $2M | Sell |
111,299
-177,110
| -61% | -$3.18M | ﹤0.01% | 2238 |
|
|
2023
Q2 | $5.86M | Buy |
288,409
+252,847
| +711% | +$5.14M | ﹤0.01% | 1372 |
|
|
2023
Q1 | $649K | Buy |
35,562
+9,698
| +37% | +$177K | ﹤0.01% | 3377 |
|
|
2022
Q4 | $535K | Sell |
25,864
-7,967
| -24% | -$165K | ﹤0.01% | 3313 |
|
|
2022
Q3 | $885K | Buy |
33,831
+21,725
| +179% | +$568K | ﹤0.01% | 2931 |
|
|
2022
Q2 | $307K | Sell |
12,106
-12,755
| -51% | -$323K | ﹤0.01% | 4072 |
|
|
2022
Q1 | $785K | Buy |
+24,861
| New | +$785K | ﹤0.01% | 3244 |
|
|
2021
Q4 | – | Sell |
-22,515
| Closed | -$786K | – | 5818 |
|
|
2021
Q3 | $786K | Buy |
+22,515
| New | +$786K | ﹤0.01% | 2925 |
|
|
2021
Q2 | – | Sell |
-19,997
| Closed | -$562K | – | 5663 |
|
|
2021
Q1 | $562K | Buy |
19,997
+11,194
| +127% | +$315K | ﹤0.01% | 3213 |
|
|
2020
Q4 | $228K | Sell |
8,803
-6,107
| -41% | -$158K | ﹤0.01% | 3378 |
|
|
2020
Q3 | $256K | Sell |
14,910
-8,345
| -36% | -$143K | ﹤0.01% | 3010 |
|
|
2020
Q2 | $575K | Buy |
+23,255
| New | +$575K | ﹤0.01% | 2403 |
|
|
2019
Q1 | – | Sell |
-29,957
| Closed | -$323K | – | 3652 |
|
|
2018
Q4 | $323K | Buy |
+29,957
| New | +$323K | ﹤0.01% | 2482 |
|